Quantitative detection of RT activity by PERT assay:: Feasibility and limits to a standardized screening assay for human vaccines

被引:14
作者
André, M [1 ]
Morgeaux, S [1 ]
Fuchs, F [1 ]
机构
[1] Agence Francaise Secur Sanitaire Produits Sante, Direct Labs & Controles, Unite Controle Medicaments Immunol, F-69007 Lyon, France
关键词
RT assay; retroviral detection; viral safety; vaccine;
D O I
10.1006/biol.2000.0243
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The detection of adventitious retroviruses has always been critical for assessing the safety concerns associated with viral vaccines. Assays for the enzymatic activity of reverse transcriptase (RT) are used as general methods for the detection of both known and unknown retroviruses. Several studies using newly-developed ultrasensitive PCR-based RT assays reported RT activity in viral vaccines grown in chicken cells. Here, we have assessed the performances of such a PCR-based RT assay-PERT assay-for the quantitative detection of RT activity in vaccines. Sensitivity, linearity and reproducibility of the method were studied on purified RT and viral vaccines treated to release RT from potentially contaminant retroviruses. The level of RT activity detected in chicken cell-derived vaccines was higher for live attenuated vaccines compared to inactivated ones. Contrary to other studies, RT activity was found in some mammalian cell-derived vaccines. AZT-TP sensitivity of RT activities detected in these vaccines and discrimination between retroviral and RT-like activities was further investigated. Feasibility and limits of PERT assay as a broad-spectrum retroviruses detection method in vaccines are discussed.
引用
收藏
页码:67 / 80
页数:14
相关论文
共 35 条
[1]   One-step fluorescent probe product-enhanced reverse transcriptase assay [J].
Arnold, BA ;
Hepler, RW ;
Keller, PM .
BIOTECHNIQUES, 1998, 25 (01) :98-+
[2]   Detection of reverse transcriptase activity in live attenuated virus vaccines [J].
Boni, J ;
Stalder, J ;
Reigel, F ;
Schupbach, J .
CLINICAL AND DIAGNOSTIC VIROLOGY, 1996, 5 (01) :43-53
[3]   CHARACTERIZATION OF AN HIV-1 ISOLATE DISPLAYING AN APPARENT ABSENCE OF VIRION-ASSOCIATED REVERSE-TRANSCRIPTASE ACTIVITY [J].
BUCKHEIT, RW ;
SWANSTROM, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (03) :295-303
[4]  
Cech TR, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1202
[5]   Development of an improved product enhanced reverse transcriptase assay [J].
Chang, A ;
Ostrove, JM ;
Bird, RE .
JOURNAL OF VIROLOGICAL METHODS, 1997, 65 (01) :45-54
[6]  
Clementi M, 1993, PCR Methods Appl, V2, P191
[7]  
Coffin JM, 1996, RETROVIRIDAE VIRUSES
[8]   A NEW METHOD FOR MEASURING REVERSE-TRANSCRIPTASE ACTIVITY BY ELISA [J].
EBERLE, J ;
SEIBL, R .
JOURNAL OF VIROLOGICAL METHODS, 1992, 40 (03) :347-356
[9]  
GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817
[10]   Effects of non-nucleoside inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assays [J].
Gu, ZX ;
Quan, YD ;
Li, Z ;
Arts, EJ ;
Wainberg, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (52) :31046-31051